Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-232931
Filing Date
2017-07-21
Accepted
2017-07-21 17:03:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3/A d422951ds3a.htm S-3/A 368057
2 OPINION OF AKERMAN LLP d422951dex51.htm EX-5.1 26620
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d422951dex231.htm EX-23.1 1536
5 GRAPHIC g422951g05t28.jpg GRAPHIC 48548
6 GRAPHIC g422951g0712055327746.jpg GRAPHIC 1552
7 GRAPHIC g422951g0721182923693.jpg GRAPHIC 1552
8 filename8.htm CORRESP 8045
  Complete submission text file 0001193125-17-232931.txt   477182
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-219259 | Film No.: 17977113
SIC: 2834 Pharmaceutical Preparations